BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 30, 2009
View Archived Issues
Meta-analyses describe the effects of liraglutide in type 2 diabetes
Read More
WAY-364416 potentiates the activity of known antipsychotics, improves cognitive function
Read More
Improved endothelial function seen with insulin VIAject in type 2 diabetes
Read More
LBH-589, a promising candidate for the treatment of spinal muscular atrophy
Read More
Yuhan Research Institute discovers glucokinase activator with antidiabetes potential
Read More
RaQualia Pharma reports on novel TRPM8 antagonists as analgesic candidates
Read More
INK-055 shows promise in mouse model of collagen-induced arthritis
Read More
Champions Biotechnology signs licensing agreement with Ramot for TAR-1
Read More
FDA approves assay to aid in the diagnosis of rheumatoid arthritis
Read More
Astellas submits MAA to EMEA for telavancin for nosocomial pneumonia and cSSTI
Read More
Sanofi-aventis and Micromet sign license agreement for solid tumor BiTE antibody
Read More
Daiichi submits application to manufacture and market levofloxacin injection in Japan
Read More
Sangamo BioSciences receives CIRM award to develop ZFN-based therapy for AIDS
Read More
Cyclacel reports survival data from phase II sapacitabine trial in elderly AML patients
Read More
Ipsen's taspoglutide meets primary endpoint in Roche's first phase III trial in diabetes
Read More
Amgen reports results of third quarter of 2009
Read More
Cardiome and Astellas initiate enrollment in phase III trial of Kynapid for AF
Read More
Purinergic receptor antagonists discovered by Renovis for the treatment of pain
Read More
SYK and Janus kinase inhibitors claimed by Roche for autoimmune disorders
Read More
Wyeth discloses novel PI3K inhibitors for cancer treatment
Read More
Kowa describes new LXRbeta agonists
Read More
Paion's short-acting anesthetic/sedative CNS-7056 meets phase Ib trial endpoint
Read More
Forest Laboratories reports results from phase IIb cariprazine study in schizophrenia
Read More
AdvanDx receives FDA clearance for its 90-minute E. faecalis test
Read More
Rules-Based Medicine launches CardiovascularMAP
Read More
FDA clears D3 FastPoint L-DFA influenza A/influenza B virus identification kit
Read More